UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058748
Receipt number R000067173
Scientific Title A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders
Date of disclosure of the study information 2025/08/09
Last modified on 2025/08/09 12:20:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders

Acronym

A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders

Scientific Title

A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders

Scientific Title:Acronym

A Retrospective Study on Treatment Outcomes for Lymphedema and Lymphatic Disorders

Region

Japan


Condition

Condition

Lymphedema and Lymphatic Disorders

Classification by specialty

Plastic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To retrospectively analyze treatment outcomes for lymphedema and other lymphatic disorders at our institution, and to evaluate the usefulness and validity of our diagnostic and therapeutic approaches.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in clinical symptoms and anthropometric measurements before and after treatment (e.g., limb circumference, severity of edema, skin changes)
Changes in functional status (e.g., activities of daily living [ADL] scores, patient-reported outcomes)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who visited the Mukumi Clinic between November 1, 2018, and March 31, 2025, and were diagnosed with lymphedema or other lymphatic disorders.

Key exclusion criteria

1. Patients deemed unsuitable for inclusion in the study by the principal investigator.
2. Patients who declined to participate in the study.

Target sample size

989


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Mihara

Organization

Mukumi Clinic

Division name

Clinical Department

Zip code

151-0053

Address

3F, toDOe Yoyogi Building, 1-35-3 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan

TEL

050-3146-4579

Email

mihara.plasticsurgery@gmail.com


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Mihara

Organization

Clinical Department

Division name

Clinical Department

Zip code

151-0053

Address

3F, toDOe Yoyogi Building, 1-35-3 Yoyogi, Shibuya-ku, Tokyo, 151-0053, Japan

TEL

050-3146-4579

Homepage URL


Email

mihara.plasticsurgery@gmail.com


Sponsor or person

Institute

Mukumi Clinic

Institute

Department

Personal name



Funding Source

Organization

Non

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Aichi Medical University

Address

1-1 Yazako Karimata, Nagakute, Aichi 480-1195, Japan

Tel

0561-62-3311

Email

amu_crb@aichi-med-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

1000

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2025 Year 07 Month 15 Day

Date of IRB

2025 Year 07 Month 15 Day

Anticipated trial start date

2025 Year 07 Month 15 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a single-center, retrospective observational study.
The study will include patients who visited Mukumi Clinic between November 1, 2018, and March 31, 2025, and were diagnosed with lymphedema or other lymphatic disorders.
Medical records will be reviewed to evaluate the usefulness and validity of diagnostic and therapeutic approaches.


Management information

Registered date

2025 Year 08 Month 09 Day

Last modified on

2025 Year 08 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067173